Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 November 2021 | Story Elna Van Pletzen

The Council of the University of the Free State (UFS) is seeking to co-opt a suitable candidate to serve for a period of four (4) years on the Finance Committee of Council. To this end, nominations for suitably qualified and experienced candidates are invited.

The Finance Committee of Council exercises oversight over the financial and investment portfolio of the UFS.

Candidates must be suitably qualified with requisite knowledge and experience of financial matters (including investments and acquisitions that are material to the UFS’s business). An appropriate qualification in the financial field is required, as is registration with the relevant professional bodies. 

Nominations must be submitted on the prescribed Nomination form, together with detailed curricula vitae, to the Registrar of the UFS at registrar@ufs.ac.za before 16:30 on 12 January 2022.

The Nominations Committee of Council will consider all the nominations and make a recommendation to the Council, which will decide whether to co-opt any of the candidates. 

The Finance Committee meets at least four times per year, or more frequently as may be necessary. 

The Council may decide not to co-opt any of the candidates.  

For enquiries, you may contact Mr NN Ntsababa at registrar@ufs.ac.za or telephone number +27 51 401 3796.

News Archive

Newly operational sequencing unit in genomics at UFS
2016-09-09

Description: Next Generation Sequencing  Tags: Next Generation Sequencing

Dr Martin Nyaga and his research assistant,
Tshidiso Mogotsi in the Next Generation
Sequencing Laboratory.
Photo: Charl Devenish

The Next Generation Sequencing (NGS) unit at the UFS was established as an interdisciplinary facility under the Directorate for Research Development, Faculty of Health Sciences and Faculty of Natural and Agricultural Sciences.

The aim of the NGS facility is to aid internal and external investigators undertaking studies on Deoxyribonucleic acid (DNA) sequencing, assembly and bioinformatics approaches using the more advanced Illumina MiSeq NGS platform.

The NGS unit became operational in 2016 and is managed by Dr Martin Nyaga and administered through the office of the Dean, Faculty of Health Sciences, under the leadership of Prof Gert Van Zyl. Dr Nyaga has vast experience in microbial genomics, having done his PhD in Molecular Virology.

He has worked and collaborated with globally recognised centres of excellence in Prokaryotic and Eukaryotic genomics, namely the J. Craig Venter Institute and the Laboratory of Viral Metagenomics, Rega Institute, among others.

The unit has undertaken several projects and successfully generated data on bacterial, viral and human genomes. Currently, work is ongoing on bacterial and fungal metagenomics studies through 16S rRNA sequencing.

In addition, the unit is also working on plasmid/insert sequencing and whole genome sequencing of animal and human rotaviruses. The unit has capacity to undertake other kinds of panels like the HLA, Pan-cancer and Tumor 15 sequencing, among others.

Several investigators from the UFS including but not limited to Prof Felicity Burt, Prof Wijnand Swart, Dr Frans O’Neil, Dr Trudi O'Neill, Dr Charlotte Boucher, Dr Marieka Gryzenhout and Dr Kamaldeen Baba are actively in collaboration with the NGS unit.

The unit has also invested in other specialised equipment such as the M220 Focused-ultrasonicator (Covaris), 2100 Bioanalyzer system (Agilent) and the real-time PCR cycler, the Rotor-Gene Q (Qiagen), which both the UFS and external investigators can use for their research.

Investigators working on molecular and related studies are encouraged to engage with Dr Nyaga on how they would like to approach their genomics projects at the UFS NGS unit. 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept